This indirect method for determination of desferrioxamine (DFO, deferoxamine, Desferal#{174}) and its chelated compounds ferrioxamine (FO) and aluminoxamine (AlO) in biological fluids involves metal chelate formation and solvent extraction, the metal being determined by Zeeman atomic absorption spectrometry (Zeeman-AAS). Special attention was paid to the pH and recovery of extraction, iron-aluminum interactions, extraction times and volumes, centnfugation rates, and instrument settings. Precautions were taken to avoid contamination with aluminum and iron and to prevent co-extraction of iron and aluminum not chelated to DFO. The addition calibration technique was used for standardization. Mean ± SD recoveries of AlO and EQ after extraction were respectively 98.3% ± 3.7% and 101% ± 3.7%. 
This indirect method for determination of desferrioxamine (DFO, deferoxamine, Desferal#{174}) and its chelated compounds ferrioxamine (FO) and aluminoxamine (AlO) in biological fluids involves metal chelate formation and solvent extraction, the metal being determined by Zeeman atomic absorption spectrometry (Zeeman-AAS). Special attention was paid to the pH and recovery of extraction, iron-aluminum interactions, extraction times and volumes, centnfugation rates, and instrument settings. Precautions were taken to avoid contamination with aluminum and iron and to prevent co-extraction of iron and aluminum not chelated to DFO. The addition calibration technique was used for standardization. Mean ± SD recoveries of AlO and EQ after extraction were respectively 98.3% ± 3.7% and 101% ± 3.7%. Sensitivity was 45 p9/0.0044 A s for aluminum and 10 pg/0.0044 A#{149} s for iron. Detection limits were 0.22 j.mol/L for AlO, 0.06 Mmol/L for DFO and FO.
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Desferrioxamine (DFO) isa trihydroxamic acidobtained from isolates of an actinomycete, Streptomyces pilosus (1).1 DFO effectively chelates trivalent ions such as iron(K5 = 10'). It has therefore been widely used to remove chelated iron via the kidney in patientswith iron overload (2) . Although it has been known forsome time that DFO also forms a complex with aluminum (K8 = 1022) (3), thechelator has been used in the diagnosis and therapy of aluminum accumulation/toxicity in dialysis patients only since 1980 (4 
Materials and Methods

Principle of the Speciation of the Different Compounds
Precautions to Avoid Contamination
All materials coming in contact with the samples were tested as potential sources ofaluminum oriron. Reagents or othermaterialsthatleachedany detectable iron or aluminum during the different steps of the assay were discarded.
Sampling
Venipuncture, serum sampling, and urine collection and storage were alldone as described elsewhere (12). the benzyl alcoholextract. However, the followingconditionsare critical. The extraction must be performed at a pH -near 7, because atacidpH (<3)smallamounts offreeiron or aluminum are co-extracted. Furthermore, the extraction layer was free of aluminum and irononly when centrifugation was performed at at least 15000 x g for 20 mm.
Sample Preparation
Moreover, the added NaCI must be in excess (0.5 g) if the two layers are to separate well,with no formationof an emulsion.
Benzyl alcohol has a density of 1.05 g/mL, so addition of NaCI is necessary to increase the density of the aqueous layer(>1.05g/mL),allowingthe benzyl alcoholto become the upper layer,which facilitates manipulation of the extract.
To see whether, during sample preparation, the phosphate buffer or the NaC1 leached any Fe or Al3, we added both reagents to doubly distilled water containing 22.9 mol of unchelated DFO per liter, then treatedtheseas ifthey were urine or serum specimens. After extraction, no MO or FO couldbe detected in the supernates.
Evidentlyneither reagent contained detectable ironor aluminum that could convert unchelated DFO intoFO or MO.
Analytical performance.
The sensitivity, determined as the mass of the element generating a 1% absorption signal (0.0044 A . s),was 45 pg foraluminum and 10 pg foriron, corresponding toa sensitivity of0.97ng forMO and 0.11 ng forDFO and FO. Detectionlimits, determinedas blank + 3 x SD, were 0.22 tmolfL forMO and 0.06 unoI/L for Table 3 . Results ofthe analytical cross-check forFO inurine(n = 6) showed a good correlation, r = 0.9997, between our experimental results (y) and the true values(x), the equation of the best-fitting line being y = 0.9438x + 2.3043. Results of FO measurement in plasma (n = 12) were slightly high.This was found to be becausethe plasma we used to prepare the supplemented samples contained a considerable amount ofmobilizable iron,12.5pmol(L. Consequently, part ofthe added unchelated DFO was converted intoFO. After correction forthis, the results were closeto the true value,as indicated by the linearregression: y = 1.0436x -0.1572 (r = 0.9906) . FO concentrations ranged between 5.4 and 492.3 nmollg forurine and between 0.51 and 49.96 nmollg forserum.
As for FO, the experimentallyfound concentrations of unchelatedDFO alsoagreed well with the true values,as indicated by the equationforthe lineofbestfit: y = 0.9980x We used the method ofjointconfidence regionsto determine the analytical performanceofthe unchelatedDFO + FO measurement in serum and in urine (Figure1).With this method a 95% confidence ellipse was constructed, having the pointofbestfitas center. The area coveredby the ellipse isdetermined by the magnitude of confidence. This method demonstrates that indirect Zeeman-AAS is more nearlyaccurateand more precise than HPLC.
Discussion
Previously used methods based on the spectroscopic properties of the FO chromophore (Xm = 450 nm) have thus far failed to attain the sensitivity required for DFO measurement in the concentration range observed in patients being treated with DFO under certain conditions. Therefore, until recently (1985), the pharmacokinetics and monitoring of DFO and itschelated compounds in patients undergoing long-term DFO therapy have not been examined. Furthermore, the specificity of these methods is questionable because ofinterference by pigments and drugs (8, 9) . The lackofsensitivity has been overcome by usingHPLC ordifferential pulsepolarography, orwith indirect methods The ICPES (8) and polarographic (7) methods,however,do notallowdetermination of MO. Hitherto, thebestresults have been obtained by HPLC (9, 10) or atomic absorptionspectrometry(11). We have found HPLC tobe lesssuitable forroutineanalysis, requiringrathercomplex and laborious procedures forpurification and pretreatmentofsamples. Besidesthis, we and others (9) found that,with HPLC, part of the DFO presentin the analytical samples was converted intoFO by iron mobilized from the stainless-steel plumbing system and the column during chromatography. Although both methods attain comparable sensitivities, our analytical cross-check has shown the poorer analytical performance ofHPLC. Errors in the indirectdeterminationof organic compounds by atomic absorption spectrometry mostly arise at the extraction stageswhen the metal to be determined is one that is commonly present as an impurity in thesolvents used. Moreover, with this technique one should always investigate the solubility of water in the solvent. Indeed, when the aqueous and organic phases are not separated completely, part ofthe metal-containing substances or ofthe element added in excess to form the extractable compound would notbe completely removed from theextraction layer, leadingto importantblank values (14) .
Therefore,in the selection of the appropriateorganic solvent, two main issuesmust be considered. Firstly, under specific conditions, the solvent should quantitatively and selectively extract the complex of interest. We have found that benzyl alcoholfulfills these prerequisites if(a) the extraction is performed at pH = 7; (b) sodium chlorideis added in excess; and (c) samples are centrifuged at at least 15 000 x g. Secondly, the organic solventshould allow measurement by atomic absorptionspectrometry.Here, graphite-furnace atomizationhas an advantage over flame atomization, because a wider range ofsolvents can be used (15) . However, even with electrothermal atomization, we and others (11) have founditnecessary to modify the benzyl alcohol phase. Therefore, we diluted the benzylalcohol with an equalvolume ofa 4/1 ethanol/water mixture to improve sample injection in the graphitefurnace.
Because ofitsspecificity, the proposed indirect Zeeman-AAS method issuitable forthedetermination ofDFO and of its chelated compounds MO and FO. A high sensitivity was obtained forthe different compounds, with no zerobias.If necessary, the detection limits may still be increased by eithersequential sample iujection or by increasing the injection volume (rather than decreasing the extraction volume).
The small joint-confidence ellipse and the point ofintercept = 0 and slope= 1 lying within the ellipse, as found in the analytical cross-check, show our method to be both accurate and precise and theanalytical performance to excel thatobtained with HPLC.
Relatively small sample volumes (200 1zL) are required here.Ifnecessary, inthepresenceofextremelyhigh concentrations, samples volumes can even be reduced to 25 zL. The use of smallervolumes ispreferred to dilution ofthe extraction layer, to minimize the riskofincompleteextraction. These data, together with the relative simple procedures of sample preparation and calibration and the good analytical performance, have made indirect Zeeman-AAS a valuable tool formonitoring the DFO chelation therapyand for studying the pharmacokinetics of the chelator in patients undergoing hemodialysis.
